Alexia without agraphia

disease
On this page

Also known as agnosia, visual verbalAgnosias, visual verbalagraphia, alexia withoutAgraphias, alexia withoutalexia syndrome without agraphiaalexia without Agraphiasalexias, Pureblindness, Pure WordBlindnesses, Pure WordPure alexiaPure alexia without agraphiaPure alexiasPure Word blindnessPure Word Blindnessesverbal agnosia, visualverbal Agnosias, visualvisual verbal agnosiavisual verbal Agnosiaswithout agraphia, alexia

Summary

Alexia without agraphia (MONDO:0000686) is a disease. A subtype of visual agnosia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namealexia without agraphia
Mondo IDMONDO:0000686
MeSHD020237
DOIDDOID:0060156
UMLSC0751840
MedGen155643
GARD0027561
Is cancer (heuristic)no

Also known as: agnosia, visual verbal · Agnosias, visual verbal · agraphia, alexia without · Agraphias, alexia without · alexia syndrome without agraphia · alexia without agraphia · alexia without Agraphias · alexias, Pure · blindness, Pure Word · Blindnesses, Pure Word · Pure alexia · Pure alexia without agraphia · Pure alexias · Pure Word blindness · Pure Word Blindnesses · verbal agnosia, visual · verbal Agnosias, visual · visual verbal agnosia · visual verbal Agnosias · without agraphia, alexia (+3 more)

Disease family

This is a subtype of visual agnosia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disordermental disordervisual agnosiaalexia without agraphia

Related subtypes (6): apperceptive agnosia, associative visual agnosia, color agnosia, form agnosia, topographical agnosia, alexia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.